Increased plasma nitrite level in cardiac failure

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 8, 1999, Pages 1495-1500

  Ramesh, G ^a   Varma, J S ^a   Ganguly, N K ^a   Dhawan, V ^a   Bali, H K ^a   Singh, M ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cardiac failure; Contractile dysfunction; Nitric oxide; Nitrite; Rheumatic heart disease; Valvular heart disease

Indexed keywords

NITRIC OXIDE; NITRITE;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VOLUME; HUMAN; METABOLISM; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SYSTOLE; TRICUSPID VALVE; VALVULAR HEART DISEASE;

EID: 0033178874     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.0982     Document Type: Article

References (24)

1. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T, 1993. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA 90: 347-351.
2. Brady AJB, Poole Wilson PA, Hardin SE, Warren JB, 1992. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263: H1963-H1966.
3. Cachofeiro V, Sakakibara T, Nasjeth A, 1992. Kinins, nitric oxide and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension 19: 138-145.
4. Drexler H, Hayoz D, Munzel T, 1992. Endothelial function in chronic congestive heart failure. Am J Cardiol 69(19): 1596-1601.
5. Evans HG, Lewis MJ, Shah AM, 1993. Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. Cardiovasc Res 27: 1486-1490.
6. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL, 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389.
7. 15N] nitrate in biological fluids. Anal Biochem 126: 131-138.
8. Habib F, Dutka D, Crossman D, Dakley CM, Cleland JGF, 1994. Enhanced basal nitric oxide production in heart failure: Another failed counter-regulatory vasodilator mechanism? Lancet 344: 371-373.
9. Joadeau G, Katz SD, Toussaint JF, 1993. Regional specificity of peak hyperemic response in patients with congestive heart failure: Correlation with peak aerobic capacity. J Am Coll Cardiol 22: 1399-1402.
10. Kaiser L, Spickard RC, Olivier NB, 1989. Heart failure depresses endothelium dependent responses in canine femoral artery. Am J Physiol 256: H962-H967.
11. Katz SD, Biasucci L, Sabba C, 1992. Impaired endothelium mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19: 918-925.
12. Kichuk MR, Zhang X, Oz M, 1997. Angiotensin converting enzyme inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts. Am J Cardiol 80(3A): A137-A142.
13. Kiuchi K, Sato N, Shannon RP, 1993. Depressed beta adrenoceptor and endothelium mediated vasodilation in conscious dogs with heart failure. Circ Res 73: 1013-1023.
14. Kubo SH, Rector TS, Bank AJ, 1991. Endothelium dependent vasodilation is attenuated in patients with heart failure. Circulation 84: 1589-1596.
15. Levine B, Kalman J, Mayer L, Fillit HN, Packer M, 1990. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure. N Engl J Med 323: 236-241.
16. Moncada S, Palmer RM, Higgs EA, 1991. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142.
17. Moncada S, 1992. L-Arginine nitric oxide pathway. Acta Physiol Scand 145: 201-207.
18. Ontkean M, Gay R, Greenberg B, 1991. Diminished endothelium derived relaxing factor activity in an experimental model of chronic congestive heart failure. Circ Res 69: 1088-1096.
19. Pinsky DJ, Cai B, Yang X, Rodriguez C, Siacca RR, Cannon PJ, 1995. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest 95: 677-685.
20. Rhodes PM, Leone AM, Francis PL, Struthers AD, Moncada S, 1995. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 209: 590-596.
21. Shulz R, Nava E, Moncada S, 1992. Induction and potential biological relevance of a calcium independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575-580.
22. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD, 1995. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor alpha. Br J Pharmacol 114: 27-34.
23. Tao S, McKenna T, 1994. In vitro endotoxin exposure reduces contractile function in adult rat cardiac myocytes. Am J Physiol 267: H1745-H1752.
24. Zelis R, Mason DT, Braunwald E, 1968. A comparison of the effect of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 47: 960-970.